{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:49:50Z","timestamp":1761821390046},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantationreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.trre.2016.09.002","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T22:30:10Z","timestamp":1473978610000},"page":"115-120","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Ana","family":"Rocha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00edsa","family":"Lobato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2016.09.002_bb0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/13506129.2011.574354017","article-title":"Amyloid detection and typing: summary of current practice and recommendations of the consensus group","volume":"18","author":"Picken","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.trre.2016.09.002_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","article-title":"CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings","volume":"86","author":"Maia","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.trre.2016.09.002_bb0015","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.08720811","article-title":"Transthyretin amyloidosis and the kidney","volume":"7","author":"Lobato","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2016.09.002_bb0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ndt\/18.3.532","article-title":"Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy","volume":"18","author":"Lobato","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2016.09.002_bb0025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1053\/ajkd.1998.v31.pm9631837","article-title":"Familial amyloid Plyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits","volume":"31","author":"Lobato","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2016.09.002_bb0030","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/lt.24058","article-title":"Liver transplantation in transthyretin amyloidosis: issues and challenges","volume":"21","author":"Carvalho","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2016.09.002_bb0035","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00007890-200203150-00015","article-title":"Suhr OB progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type","volume":"73","author":"Olofsson","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2016.09.002_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.md.0000232559.22098.c3","article-title":"Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy","volume":"85","author":"Delahaye","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.trre.2016.09.002_bb0045","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2169\/internalmedicine.47.1399","article-title":"Evaluation of myocardial changes in familial amyloid polyneuropathy after liver transplantation","volume":"47","author":"Okamoto","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.trre.2016.09.002_bb0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1600-0420.2007.01098.x","article-title":"Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy","volume":"86","author":"Sandgren","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.trre.2016.09.002_bb0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archophthalmol.2009.390","article-title":"Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients","volume":"128","author":"Hara","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.trre.2016.09.002_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/13506129.2014.989318","article-title":"Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis","volume":"22","author":"Beir\u00e3o","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.trre.2016.09.002_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/13506120309041734","article-title":"Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy, Portuguese type (Val30Met)","volume":"10","author":"Suhr","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.trre.2016.09.002_bb0070","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/lt.23522","article-title":"Renal dysfunction in liver transplant recipients: evaluation of critical issues","volume":"18","author":"Weber","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2016.09.002_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-9-61","article-title":"THAOS: gastrointestinal manifestations of transthyretin amyloidosis \u2013 common complications of a rare disease","volume":"9","author":"Wixner","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.trre.2016.09.002_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/kisup.2012.77","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.trre.2016.09.002_bb0085","first-page":"1","article-title":"Urinary biomarkers for kidney disease in ATTR amyloidosis","volume":"4","author":"Rocha","year":"2014","journal-title":"J Nephrol Ther"},{"key":"10.1016\/j.trre.2016.09.002_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/lv.2000.6145","article-title":"Liver transplantation for hereditary transthyretin amyloidosis","volume":"6","author":"Suhr","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2016.09.002_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/13506120600722662","article-title":"Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients","volume":"13","author":"Oguchi","year":"2006","journal-title":"Amyloid"},{"key":"10.1016\/j.trre.2016.09.002_bb0100","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1002\/lt.21900","article-title":"Outcomes after liver transplantation: chronic kidney disease","volume":"15","author":"Bahirwani","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2016.09.002_bb0105","first-page":"199","article-title":"Orthotopic liver transplantation in familial amyloidotic polyneuropathy is associated with long-term progression of renal disease","volume":"26","author":"Ferreira","year":"2012","journal-title":"Port J Nephrol Hypert"},{"key":"10.1016\/j.trre.2016.09.002_bb0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-6143.2006.01585.x","article-title":"Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients","volume":"7","author":"Yazaki","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2016.09.002_bb0115","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/ndt\/gfh063","article-title":"Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation","volume":"19","author":"Snanoudj","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2016.09.002_bb0120","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/S0041-1345(00)01832-7","article-title":"Remission of proteinuria following liver transplantation for familial amyloid polyneuropathy TTR Met30","volume":"32","author":"Carvalho","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2016.09.002_bb0125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00595-010-4488-5","article-title":"Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation","volume":"41","author":"Ohya","year":"2011","journal-title":"Surg Today"},{"key":"10.1016\/j.trre.2016.09.002_bb0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1432-2277.2004.00015.x","article-title":"The long-term impact of liver transplantation on kidney function in familial amyloidotic polyneuropathy patients","volume":"18","author":"Nowak","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2016.09.002_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13506120410001673884","article-title":"End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors","volume":"11","author":"Lobato","year":"2004","journal-title":"Amyloid"},{"key":"10.1016\/j.trre.2016.09.002_bb0140","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1540-8159.1984.tb05599.x","article-title":"Pacemaker treatment in familial amyloidosis with polyneuropathy","volume":"7","author":"Eriksson","year":"1984","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.trre.2016.09.002_bb0145","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ndt\/gfh628","article-title":"Central venous stenosis as a complication of ipsilateral haemodialysis fistula and pacemaker","volume":"20","author":"Tourret","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2016.09.002_bb0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.transproceed.2010.11.014","article-title":"Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M)","volume":"43","author":"Rocha","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2016.09.002_bb0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/00365529208999949","article-title":"Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy","volume":"27","author":"Suhr","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trre.2016.09.002_bb0160","first-page":"130","article-title":"Bowel bacterial overgrowth as another cause of malnutrition, inflammation, and atherosclerosis syndrome in peritoneal dialysis patients","volume":"26","author":"Aguilera","year":"2010","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.trre.2016.09.002_bb0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.jrn.2013.01.031","article-title":"Nutritional issues in peritoneal dialysis patients: how do they differ from that of patients undergoing hemodialysis?","volume":"23","author":"Mehrotra","year":"2013","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.trre.2016.09.002_bb0170","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/AEM.05605-11","article-title":"Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients","volume":"78","author":"Wang","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.trre.2016.09.002_bb0175","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ndt\/gfl760","article-title":"Influence of autonomy and type of home assistance on the prevention of peritonitis in assisted automated peritoneal dialysis patients. An analysis of data from the French language peritoneal dialysis registry","volume":"22","author":"Verger","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2016.09.002_bb0180","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/tri.12235","article-title":"Domino liver transplantation as a valuable option","volume":"27","author":"Yamamoto","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2016.09.002_bb0185","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1111\/ajt.12378","article-title":"Reversibility of acquired amyloid polyneuropathy after liver retransplantation","volume":"13","author":"Antonini","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2016.09.002_bb0190","author":"FAPWTR"},{"key":"10.1016\/j.trre.2016.09.002_bb0195","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.transproceed.2010.05.070","article-title":"Thirteen cases of liver\u2013kidney transplantation","volume":"42","author":"Gonz\u00e1lez","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2016.09.002_bb0200","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/13506129.2011.574354071","article-title":"Combined liver\u2013kidney transplantation in familial amyloidotic polyneuropathy TTR V30M: nephrological assessment","volume":"18","author":"Lobato","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.trre.2016.09.002_bb0205","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0041-1345(03)00331-2","article-title":"End-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver\u2013kidney transplantation","volume":"35","author":"Lobato","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2016.09.002_bb0210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1751-7133.2012.00303.x","article-title":"Diflunisal for ATTR cardiac amyloidosis","volume":"18","author":"Casta\u00f1o","year":"2012","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.trre.2016.09.002_bb0215","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Diflunisal trial consortium repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2016.09.002_bb0220","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.trre.2016.09.002_bb0225","series-title":"Treatment of ATTR V30M with tafamidis: successful decrease of proteinuria. [abstrat PC-42]","author":"Rocha","year":"2014"},{"key":"10.1016\/j.trre.2016.09.002_bb0230","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2016.09.002_bb0235","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.gt.3302480","article-title":"Exploring RNA interference as a therapeutic strategy for renal disease","volume":"12","author":"Takabatake","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.trre.2016.09.002_bb0240","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1681\/ASN.2009030295","article-title":"siRNA-based therapy ameliorates glomerulonephritis","volume":"21","author":"Shimizu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2016.09.002_bb0250","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jhep.2013.05.045","article-title":"Liver as a target for oligonucleotide thaerapeutics","volume":"59","author":"Sehgal","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2016.09.002_bb0255","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/13506129.2012.673140","article-title":"Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy","volume":"19","author":"Ackermann","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.trre.2016.09.002_bb0260","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/ki.1995.205","article-title":"Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy","volume":"47","author":"Rappaport","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2016.09.002_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-8-74","article-title":"Synergy of combined doxycycline\/TUDCA treatment in lowering transthyretin deposition and associated biomarkers: studies in FAP mouse models","volume":"8","author":"Cardoso","year":"2010","journal-title":"J Transl Med"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X16300714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X16300714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T07:33:08Z","timestamp":1536391988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X16300714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0955470X16300714"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2016.09.002","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2016.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}